Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | JAK2 | O60674 | 1/20 | 0.31 |
| ▸ | TYK2 | P29597 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL29050810 | 1.00 | NAPRT (0.69) | NAPRTTSHRTDP1TAAR1NOTUM | |
| Pyridine SCHEMBL28266003 | 0.96 | TSHR (0.64) | NAPRTTSHRTDP1TAAR1NOTUM | |
| Pyridine SCHEMBL28067297 | 0.88 | NAPRT (0.90) | NAPRTTSHRTDP1TAAR1NOTUM | |
| Pyridine SCHEMBL6532110 | 0.88 | — | — | |
| Pyridine SCHEMBL9214704 | 0.86 | TSHR (0.60) | NAPRTTSHRTDP1TAAR1NOTUM | |
| Pyridine SCHEMBL9214710 | 0.86 | TSHR (0.60) | NAPRTTSHRTDP1TAAR1NOTUM | |
| Pyridine SCHEMBL28910607 | 0.84 | NAPRT (0.82) | NAPRTTSHRTDP1TAAR1NOTUM | |
| Pyridine SCHEMBL1206485 | 0.84 | — | — | |
| Pyridine SCHEMBL15309118 | 0.84 | NAPRT (0.82) | NAPRTTSHRTDP1TAAR1NOTUM | |
| Pyridine SCHEMBL2348132 | 0.84 | NAPRT (0.82) | NAPRTTSHRTDP1TAAR1NOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110551036-B | Iridium/chiral phosphite ester-pyridine catalyzed imine asymmetric hydrogenation method | 中国科学院大连化学物理研究所 | 2022-04-12 | — | — | CN | claimed |
| EP-3110825-B1 | NOVEL SYNTHETIC OLIGOMERS OF NEISSERIA MENINGITIS SEROGROUP X AND PROCESS OF PREPARING THEM | MSD WELLCOME TRUST HILLEMAN LABORATORIES PVT LTD (IN) | 2020-12-09 | — | — | EP | claimed |
| CN-110551036-A | iridium/chiral phosphite ester-pyridine catalyzed imine asymmetric hydrogenation method | DALIAN INST CHEM & PHYSICS CAS | 2019-12-10 | — | — | CN | claimed |
| US-10183962-B2 | Synthetic oligomers of Neisseria meningitis serogroup X and process of preparing them | MSD WELLCOME TRUST HILLEMAN LABORATORIES PVT. LTD. (IN) | 2019-01-22 | — | — | US | claimed |
| CN-108707202-A | A kind of new and effective polymerization inhibitor and its application method for preventing alpha-olefin polymerization | 碳氢联合科技（北京）有限公司 | 2018-10-26 | — | — | CN | claimed |
| US-20170066794-A1 | NOVEL SYNTHETIC OLIGOMERS OF NEISSERIA MENINGITIS SEROGROUP X AND PROCESS OF PREPARING THEM | MSD WELLCOME TRUST HILLEMAN LABORATORIES PVT. LTD. (IN) | 2017-03-09 | — | — | US | claimed |
| EP-3110825-A1 | NOVEL SYNTHETIC OLIGOMERS OF NEISSERIA MENINGITIS SEROGROUP X AND PROCESS OF PREPARING THEM | Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. (IN) | 2017-01-04 | — | — | EP | claimed |
| WO-2015128797-A1 | NOVEL SYNTHETIC OLIGOMERS OF NEISSERIA MENINGITIS SEROGROUP X AND PROCESS OF PREPARING THEM | MSD WELLCOME TRUST HILLEMAN LABORATORIES PVT. LTD. (IN) | 2015-09-03 | — | — | WO | claimed |
| CN-117903297-A | Chemoselective coupling of sulfhydryl groups with alkenyl or alkynyl phosphoramides | 柏林合作研究学会 | 2024-04-19 | — | — | CN | disclosed |
| CN-109689112-B | Chemoselective coupling of sulfhydryl groups with alkenyl or alkynyl phosphoramides | 柏林合作研究学会 | 2023-10-13 | — | — | CN | disclosed |
| CN-116348452-A | Asymmetric transfer hydrogenation of 2-aryl substituted bicyclic pyridones in the presence of chiral ruthenium catalysts | 拜耳公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-110551036-B | Iridium/chiral phosphite ester-pyridine catalyzed imine asymmetric hydrogenation method | 中国科学院大连化学物理研究所 | 2022-04-12 | — | — | CN | disclosed |
| EP-3110825-B1 | NOVEL SYNTHETIC OLIGOMERS OF NEISSERIA MENINGITIS SEROGROUP X AND PROCESS OF PREPARING THEM | MSD WELLCOME TRUST HILLEMAN LABORATORIES PVT LTD (IN) | 2020-12-09 | — | — | EP | disclosed |
| CN-110551036-A | iridium/chiral phosphite ester-pyridine catalyzed imine asymmetric hydrogenation method | DALIAN INST CHEM & PHYSICS CAS | 2019-12-10 | — | — | CN | disclosed |
| US-6080833-A | BIS(HYDROXYALKOXYLATED) 1,1'-SPIROBIINDAN POLYCARBONATES AND POLYESTERS POLYMERS AND CURABLE COMPOUNDS SUCH AS BIS(ACRYLATED ALKOXY)SPIROBIINDANS; ALSO POLYAMIDES AND POLYIMIDES CONTAINING SPIROBIINDAN GROUPS | MITSUI CHEMICALS, INC. (JP) | 2000-06-27 | — | — | US | disclosed |
| US-5990261-A | Organic optical component | MITSUI CHEMICALS, INC. (JP) | 1999-11-23 | — | — | US | disclosed |
| CN-1175600-A | Low-birefringent organic optical component and spirobiindan polymer | MITSUI TOATSU CHEMICALS (JP) | 1998-03-11 | — | — | CN | disclosed |
| EP-0826717-A1 | An organic optical component | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1998-03-04 | — | — | EP | disclosed |
| EP-0822545-A2 | Optical component and spirobiindan polymer therefor | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1998-02-04 | — | — | EP | disclosed |
| US-5686557-A | Polyamide resin which can be dissolved in alcohol solvent, composition thereof, and method of use thereof | TOMOEGAWA PAPER CO., LTD. (JP) | 1997-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170066794-A1 | NOVEL SYNTHETIC OLIGOMERS OF NEISSERIA MENINGITIS SEROGROUP X AND PROCESS OF PREPARING THEM | MLEC, MEN1, MAN2B2 | NAPRT 173/4885TSHR 4302/4885TDP1 4208/4885 |
| US-10183962-B2 | Synthetic oligomers of Neisseria meningitis serogroup X and process of preparing them | MLEC, MEN1, MAN2B2 | NAPRT 176/4885TSHR 4300/4885TDP1 4203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.